Physical interaction between pRb and cdk9/cyclinT2 complex.

The study aimed to investigate whether cdk9/cyclinT2 interacts with pRb in human cell lines both in vitro and in vivo. The primary goal was to determine the specific regions of cdk9 and pRb involved in this interaction. Researchers sought to identify the minimal region of cdk9 responsible for phosphorylation of pRb. They also aimed to locate the phosphorylation sites on pRb that are targeted by cdk9. The study focused on residues within the C-terminal domain of pRb, particularly between amino acids 835 and 928. The researchers wanted to confirm whether these residues are phosphorylated in vivo and whether they are accessible to cdk9. The ultimate aim was to assess the functional implications of this interaction in nuclear signal transduction. By mapping phosphorylation sites and interaction domains, the study contributes to understanding how cdk9 might modulate pRb activity in transcriptional regulation.

The researchers used in vitro and in vivo assays to detect interactions between cdk9/cyclinT2 and pRb. They employed co-immunoprecipitation techniques to confirm physical association in human cell lines. To identify interaction domains, they performed region-specific deletions of cdk9 and pRb. The study utilized recombinant proteins to map the minimal region of cdk9 involved in phosphorylation. The C-terminal domain of pRb was analyzed for phosphorylation sites using site-directed mutagenesis. Researchers used mass spectrometry to identify phosphorylated residues on pRb. They also performed kinase assays to assess the activity of cdk9 on pRb fragments. The study combined biochemical and molecular biology approaches to validate the interaction and phosphorylation mechanism.

The study confirmed both in vitro and in vivo interactions between cdk9/cyclinT2 and pRb. The interaction was localized to residues 129–195 of cdk9 and the full-length cyclinT2. The C-terminal domain of pRb (835–928) was identified as the region interacting with cdk9. The minimal phosphorylation region on pRb was mapped to residues 793–834. Three proline-directed serine residues—S795, S807, and S811—were found to be phosphorylated in vivo. These residues are potential targets for cdk9-mediated phosphorylation. The data suggest that cdk9 can phosphorylate pRb in a nuclear multiprotein complex. The findings indicate that this interaction may play a role in signal transduction to transcriptional machinery.

The authors concluded that cdk9/cyclinT2 and pRb form a physical interaction in human cells. This interaction occurs in the nucleus and may be part of a larger multiprotein complex. The phosphorylation of pRb by cdk9 is localized to the C-terminal domain. The study identified three key phosphorylation sites on pRb: S795, S807, and S811. These residues are known to be phosphorylated in vivo and are accessible to cdk9. The findings suggest that cdk9 may modulate pRb activity in transcriptional regulation. The interaction likely contributes to signal transduction within the nucleus. The authors propose that this interaction could be part of a broader regulatory mechanism involving transcriptional control.